Processa Pharmaceuticals, Inc. (PCSA) Free cash flow 2016–2024
Processa Pharmaceuticals, Inc. (PCSA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$11.2MFY2024 · since FY2016: -$2.2M → -$11.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$11.2M | -39.5% |
| FY2023 | -$8.1M | — |
| FY2017 | -$1.7M | +23.1% |
| FY2016 | -$2.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PCSA financial trends
PCSA RevenuePCSA Net incomePCSA Net marginPCSA Gross profitPCSA Gross marginPCSA Operating incomePCSA Operating marginPCSA Operating cash flowPCSA Capital expendituresPCSA Return on equityPCSA Stock buybacksPCSA Dividends paidPCSA Total assetsPCSA Total liabilitiesPCSA Shareholders’ equityPCSA overview →